Document is current
Any future updates will be listed below
-
Authors
Kawagoe, Ryosuke
Moriwaki, Toshikazu https://orcid.org/0000-0001-7702-122X
Yamazaki, Kentaro
Yukami, Hiroki
Uetake, Hiroyuki
Tsuda, Masahiro
Suto, Takeshi
Sugimoto, Naotoshi
Ojima, Hitoshi
Takii, Yasumasa
Yasui, Hisateru
Komoda, Masato
Shimada, Yasuhiro
Tsuji, Akihito
Yamaguchi, Toshifumi
Sawada, Ryoichi
Shinozaki, Katsunori
Otsu, Satoshi
Shigeyasu, Kunitoshi
Tsuchihashi, Kenji
Tamura, Takao
Shiozawa, Manabu
Ueno, Hideki
Denda, Tadamichi
Ito, Takahiko
Takashima, Atsuo
-
Funding
Funding for this research was provided by:
Asahi Kasei Pharma Corporation
Astellas Pharma
AstraZeneca KK
Incyte
Merck Sharp and Dohme K.K.
Eisai
Ono Pharmaceutical
Guardant Health Japan Corp.
Sun Pharma
Daiichi-Sankyo
Taiho Pharmaceutical
Takeda Pharmaceutical Company
Chugai Pharmaceutical
Tsumura and Company
Terumo
Eli Lilly Japan
Nippon Zoki Pharmaceutical
Novartis Pharmaceuticals Corporation
Bayer Yakuhin
Pfizer Japan
Bristol-Myers Squibb
MedPeer
Merck Biopharma
Yakult Honsha
Takata Pharmaceutical
Nihon Servier
Zeria Pharmaceutical
Amgen
Seagen
Boehringer Ingelheim Japan
- License Information
-
More Information
Article History
Received: 24 June 2025
Accepted: 22 February 2026
First Online: 4 March 2026
Declarations
:
: Naotoshi Sugimoto received honoraria from Chugai pharm, Daiichi Sankyo and Astra Zeneca, and research grant from Chugai pharm, Daiichi Sankyo, and Boehringer. Akihito Tsuji received honoraria from Asahi Kasei Pharma Corporation, Astellas Pharma Inc., Astra Zeneca, Incyte Biosciences Japan, Eisai Co., Ltd., MSD, Ono Pharmaceutical Co., Ltd., Guardant Health Japan Corp., Sun Pharmaceutical Industries Limited, Daiichi Sankyo Co., Ltd., Taiho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited, Chugai Pharmaceutical Co., Ltd., Tsumura & Co., Terumo Corporation, Eli Lilly Japan, Nippon Zoki Pharmaceutical Co., Ltd., Novartis Pharma, Bayer Yakuhin, Ltd., Pfizer Japan Inc., Bristol-Myers Squibb, MedPeer, Inc, Merck Biopharma Co., Ltd., Yakult Honsha Co., Ltd., Takata Pharmaceutical Co., Ltd., Nihon Servier Co., Ltd, and Zeria Pharmaceutical Co., Ltd.. Tadamichi Denda received research grant from Ono, Amgen, MSD, Pfizer, and Bristol Myers Squibb. Atsuo Takashima received research grant from MSD, Takeda, Astra Zeneca, Amgen, Eisai, BMS, Seagen, and Ono. All other authors declare no potential conflict of interest.
: The present study was approved from the Ethics Committee of the JSCCR. The requirement for informed consent was waived because of the retrospective design of this study.
